Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It is the largest diagnostics chain with a PAN India presence and a consistent track record of quality and growth.
1) Good fundamentals with consistent growth.
2) FII's and DII's have increased their holdings in last quater.
3) Took support from 50 EMA and trading above 20/50/100 EMA
The stock is expected to give a breakout of 2800 level this year.
1) Good fundamentals with consistent growth.
2) FII's and DII's have increased their holdings in last quater.
3) Took support from 50 EMA and trading above 20/50/100 EMA
The stock is expected to give a breakout of 2800 level this year.